Press Releases

Oct 19, 2016 3:09am EDT

CollPlant Receives CE Mark for Vergenix™STR for Treatment of Tendinopathy

Aug 17, 2016 1:23pm EDT

CollPlant Reports Positive Final Extended Clinical Trial Results with Vergenix™STR for Treatment of Tendinopathy

May 31, 2016 6:14am EDT

CollPlant Receives Chief Scientist's Authorization for a NIS 12 Million Research and Development Projects with Funding of Approximately 50%

Feb 23, 2016 2:33am EST

CollPlant Receives CE Mark for Vergenix™FG Wound Filler

Feb 04, 2016 3:22am EST

CollPlant Reports Positive Final Trial Results for Vergenix™STR, Indicated for the Treatment of Tendinopathy

Dec 08, 2015 4:47am EST

CollPlant Reports Positive Interim Trial Results for Vergenix™STR, Indicated for the Treatment of Tendinopathy

Nov 30, 2015 3:39pm EST

CollPlant Reports Positive Final Trial Results for Vergenix®FG Wound Filler

Oct 07, 2015 11:04am EDT

CollPlant Announces Completion of Patient Recruitment for Clinical Trial of Vergenix™FG (Flowable Gel) for the Treatment of Chronic Wounds

Sep 08, 2015 11:47am EDT

CollPlant to Present Results of its Product for the Treatment in Tendinopathy, at the 4th TERMIS Congress Which Will Take Place in Boston

Jul 28, 2015 3:45am EDT

CollPlant Names Shomrat Shurtz Senior Director of Business Development